journal article·2018-04-11

Using Atomic Force Microscopy to Predict Tumor Specificity of ICAM1 Antibody-Directed Nanomedicines

P. Guo, B. Wang, D. Liu, J. Yang, K. Subramanyam, C. R. McCarthy, J. Hebert, M. A. Moses, D. T. Auguste

Nano Letters· Volume 18· Issue 4
Publisher page

Abstract

Atomic force microscopy (AFM) is a powerful tool to detect in vitro antibody-antigen interactions. To date, however, AFM-measured antibody-antigen interactions have yet to be exploited to predict in vivo tumor specificity of antibody-directed nanomedicines. In this study, we have utilized AFM to directly measure the biomechanical interaction between live triple negative breast cancer (TNBC) cells and an antibody against ICAM1, a recently identified TNBC target. For the first time, we provide proof-of-principle evidence that in vitro TNBC cell-ICAM1 antibody binding force measured by AFM on live cells more precisely correlates with in vivo tumor accumulation and therapeutic efficacy of ICAM1 antibody-directed liposomes than ICAM1 gene and surface protein overexpression levels. These studies demonstrate that live cell-antibody binding force measurements may be used as a novel in vitro metric for predicting the in vivo tumor recognition of antibody-directed nanomedicines.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Force Microscopy Techniques and Applications · Nanoparticle-Based Drug Delivery · Monoclonal and Polyclonal Antibodies Research

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Department of Biomedical Engineering, The City College of New York, 160 Convent Avenue, New York, New York 10031, United States

Vascular Biology Program, Boston Children’s Hospital, 300 Longwood Avenue, Boston, Massachusetts 02115, United States

Department of Surgery, Harvard Medical School and Boston Children’s Hospital, 300 Longwood Avenue, Boston, Massachusetts 02115, United States

Department of Chemical Engineering, Northeastern University, 360 Huntington Avenue, Boston, Massachusetts 02115, United States

School of Engineering and Applied Sciences, Harvard University, 29 Oxford Street, Cambridge, Massachusetts 02115, United States

Funding

National Cancer Institute · Breast Cancer Research Foundation

References (38)

Show source-provided references
1. 10.1016/j.addr.2013.11.00910.1016/j.addr.2013.11.009 ↗
2. 10.1016/j.jconrel.2014.12.03010.1016/j.jconrel.2014.12.030 ↗
3. 10.1016/j.molmed.2015.01.00110.1016/j.molmed.2015.01.001 ↗
4. 10.1158/1538-7445.AM2015-CT23410.1158/1538-7445.AM2015-CT234 ↗
5. 10.1074/jbc.M110.21603610.1074/jbc.M110.216036 ↗
6. 10.1074/jbc.M40956520010.1074/jbc.M409565200 ↗
7. 10.1007/s10549-011-1431-410.1007/s10549-011-1431-4 ↗
8. 10.1200/JCO.2009.23.555610.1200/JCO.2009.23.5556 ↗
9. 10.1073/pnas.081061710610.1073/pnas.0810617106 ↗
10. 10.1074/jbc.M110.16643910.1074/jbc.M110.166439 ↗
11. 10.1016/j.biomaterials.2015.04.02310.1016/j.biomaterials.2015.04.023 ↗
12. 10.1073/pnas.140855611110.1073/pnas.1408556111 ↗
13. 10.7150/thno.1216710.7150/thno.12167 ↗
14. 10.1021/acs.molpharmaceut.5b0042510.1021/acs.molpharmaceut.5b00425 ↗
15. 10.7150/thno.740910.7150/thno.7409 ↗
16. 10.1021/nn507465d10.1021/nn507465d ↗
17. 10.1021/nn404792510.1021/nn4047925 ↗
18. 10.1002/advs.20150005310.1002/advs.201500053 ↗
19. 10.1073/pnas.070266810410.1073/pnas.0702668104 ↗
20. 10.1016/S1748-0132(06)70076-710.1016/S1748-0132(06)70076-7 ↗
21. 10.1073/pnas.93.8.347710.1073/pnas.93.8.3477 ↗
22. 10.1016/S0014-5793(02)03070-310.1016/S0014-5793(02)03070-3 ↗
23. 10.1016/S0005-2736(03)00016-610.1016/S0005-2736(03)00016-6 ↗
24. 10.1038/3503605210.1038/35036052 ↗
25. 10.1021/mp900309510.1021/mp9003095 ↗
26. 10.1016/S0168-3659(03)00201-310.1016/S0168-3659(03)00201-3 ↗
27. 10.1038/nrd103310.1038/nrd1033 ↗
28. 10.3109/0898210940903705710.3109/08982109409037057 ↗
29. 10.1021/nl902789s10.1021/nl902789s ↗
30. 10.1016/j.biomaterials.2010.04.04810.1016/j.biomaterials.2010.04.048 ↗
31. 10.1186/1754-1611-4-1510.1186/1754-1611-4-15 ↗
32. 10.1016/j.jconrel.2011.07.02810.1016/j.jconrel.2011.07.028 ↗
33. 10.1016/j.jconrel.2010.02.02110.1016/j.jconrel.2010.02.021 ↗
34. 10.1093/annonc/mdn71010.1093/annonc/mdn710 ↗
35. 10.1073/pnas.122076311010.1073/pnas.1220763110 ↗
36. 10.1200/JCO.2012.46.240810.1200/JCO.2012.46.2408 ↗
37. 10.1016/j.yexcr.2013.07.02010.1016/j.yexcr.2013.07.020 ↗
38. 10.1016/j.yexcr.2009.05.02310.1016/j.yexcr.2009.05.023 ↗